Evangelia E. Tsermpini
Ljubljana, Slovenia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
PharmVar GeneFocus: CYP1A2-Clinical Impact, Genetic Variation, and Updated Nomenclature.
Journal: Clinical pharmacology and therapeutics
Published: November 11, 2025
The Pharmacogenomics Global Research Network Implementation Working Group: global collaboration to advance pharmacogenetic implementation.
Journal: Pharmacogenetics and genomics
Published: November 01, 2024
PharmVar GeneFocus: CYP4F2.
Journal: Clinical pharmacology and therapeutics
Published: February 27, 2024
Genomics yields biological and phenotypic insights into bipolar disorder.
Journal: Nature
Published: December 22, 2023
The Disease Model of Addiction: The Impact of Genetic Variability in the Oxidative Stress and Inflammation Pathways on Alcohol Dependance and Comorbid Psychosymptomatology.
Journal: Antioxidants (Basel, Switzerland)
Published: November 11, 2023
Correction to: Precision Medicine in Antidepressants Treatment.
Journal: Handbook of experimental pharmacology
Published: July 17, 2023
Precision Medicine in Antidepressants Treatment.
Journal: Handbook of experimental pharmacology
Published: May 17, 2023
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants.
Journal: Clinical pharmacology and therapeutics
Published: December 02, 2022
Molecular Mechanisms Related to Responses to Oxidative Stress and Antioxidative Therapies in COVID-19: A Systematic Review.
Journal: Antioxidants (Basel, Switzerland)
Published: June 22, 2022
Alcohol-Induced Oxidative Stress and the Role of Antioxidants in Alcohol Use Disorder: A Systematic Review.
Journal: Antioxidants (Basel, Switzerland)
Published: May 31, 2022
Genetic Variability of Incretin Receptors and Alcohol Dependence: A Pilot Study.
Journal: Frontiers in molecular neuroscience
Published: March 31, 2022
miRNAs as potential diagnostic biomarkers and pharmacogenomic indicators in psychiatric disorders.
Journal: The pharmacogenomics journal
Published: January 21, 2022
Last Updated: 09/26/2026